What is it about?
The RRDY, RL and DPF were the top three out of twenty-one peptides for inhibitions against dipeptidyl peptidase-IV (DPP-IV) from the pepsin hydrolysis of yam dioscorin in silico, and were further to investigate the proof-of-concept study in normal ICR mice for regulating glucose metabolism by the oral glucose tolerance test (OGTT). The sample or sitagliptin (positive control) was orally administered by the feeding gauge, 30 min later, the glucose loads (2.5 g/kg) were performed.
Featured Image
Why is it important?
The RRDY, yam dioscorin or sitagliptin preload, but not DPF, lowered area under curve (AUC0-120) of blood glucose and DPP-IV activity, and elevated AUC0-120 of blood insulin which showed differences significantly compared to those in the control (P < 0.05 or 0.001). These results suggested that RRDY and yam dioscorin might be beneficial in glycemic controls in normal mice and need further investigations in diabetic animal models.
Perspectives
Read the Original
This page is a summary of: Synthesized Peptides from Yam Dioscorin Hydrolysis in Silico Exhibit Dipeptidyl Peptidase-IV Inhibitory Activities and Oral Glucose Tolerance Improvements in Normal Mice, Journal of Agricultural and Food Chemistry, August 2016, American Chemical Society (ACS),
DOI: 10.1021/acs.jafc.6b02403.
You can read the full text:
Resources
Contributors
The following have contributed to this page